Skip to content
10-Q

Quarterly Report

Neuphoria Therapeutics Inc. NEUP

0001193125-26-225442

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · May 14, 2026 5.4M sh
Shares Diluted Q3 2026 · Mar 31, 2026 5.41M sh
Shares Diluted Q3 2026 · Mar 31, 2026 4.06M sh
Shares Diluted Q3 2026 · Mar 31, 2025 1.72M sh
Shares Diluted Q3 2026 · Mar 31, 2025 1.53M sh
Operating Cash Flow Q3 2026 · Mar 31, 2026 −$13.57M
Operating Cash Flow Q3 2026 · Mar 31, 2025 $3.66M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $19.44M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $14.21M
Cash And Equivalents Q3 2026 · Mar 31, 2025 $17.04M
Stockholders Equity Q3 2026 · Mar 31, 2026 $29.42M
Stockholders Equity Q3 2026 · Dec 31, 2025 $29.7M
Stockholders Equity Q3 2026 · Sep 30, 2025 $12.51M
Stockholders Equity Q3 2026 · Jun 30, 2025 $19M
Stockholders Equity Q3 2026 · Mar 31, 2025 $26M
Stockholders Equity Q3 2026 · Dec 31, 2024 $13.75M
Stockholders Equity Q3 2026 · Sep 30, 2024 $17.07M
Stockholders Equity Q3 2026 · Jun 30, 2024 $17.49M
Current Liabilities Q3 2026 · Mar 31, 2026 $1.51M
Current Liabilities Q3 2026 · Jun 30, 2025 $4.22M
Total Liabilities Q3 2026 · Mar 31, 2026 $5.39M
Total Liabilities Q3 2026 · Jun 30, 2025 $9.59M
Current Assets Q3 2026 · Mar 31, 2026 $21.66M
Current Assets Q3 2026 · Jun 30, 2025 $15.04M
Total Assets Q3 2026 · Mar 31, 2026 $34.81M
Total Assets Q3 2026 · Jun 30, 2025 $28.59M
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q3 2026 · Mar 31, 2026 −$2.11
Eps Diluted Q3 2026 · Mar 31, 2025 $6.55
Eps Diluted restated Q3 2026 · Mar 31, 2025 $5.56
Eps Basic Q3 2026 · Mar 31, 2026 −$0.09
Eps Basic Q3 2026 · Mar 31, 2026 −$2.11
Eps Basic Q3 2026 · Mar 31, 2025 $6.55
Eps Basic Q3 2026 · Mar 31, 2025 $5.56
Sga Expense Q3 2026 · Mar 31, 2026 $1.69M
Sga Expense Q3 2026 · Mar 31, 2026 $5.68M
Sga Expense Q3 2026 · Mar 31, 2025 $1.41M
Sga Expense Q3 2026 · Mar 31, 2025 $5.7M
Net Income Q3 2026 · Mar 31, 2026 −$505.06K
Net Income Q3 2026 · Mar 31, 2026 −$8.55M
Net Income Q3 2026 · Dec 31, 2025 $1.86M
Net Income Q3 2026 · Sep 30, 2025 −$9.91M
Net Income Q3 2026 · Mar 31, 2025 $11.26M
Net Income Q3 2026 · Mar 31, 2025 $8.51M
Net Income Q3 2026 · Dec 31, 2024 −$1.94M
Net Income Q3 2026 · Sep 30, 2024 −$804.79K
Operating Income Q3 2026 · Mar 31, 2026 −$1.21M
Operating Income Q3 2026 · Mar 31, 2026 −$10.93M
Operating Income Q3 2026 · Mar 31, 2025 $11.98M
Operating Income Q3 2026 · Mar 31, 2025 $4.71M
Revenue Q3 2026 · Mar 31, 2025 $15M
Revenue Q3 2026 · Mar 31, 2025 $15.66M